MANDRIOLI, Jessica
 Distribuzione geografica
Continente #
NA - Nord America 10396
EU - Europa 3556
AS - Asia 455
SA - Sud America 15
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 14436
Nazione #
US - Stati Uniti d'America 10342
GB - Regno Unito 992
IT - Italia 816
SE - Svezia 686
BG - Bulgaria 314
DE - Germania 282
UA - Ucraina 179
CN - Cina 175
TR - Turchia 129
FR - Francia 101
FI - Finlandia 74
VN - Vietnam 43
MY - Malesia 34
CA - Canada 31
BE - Belgio 26
BZ - Belize 22
IN - India 21
RU - Federazione Russa 19
IR - Iran 17
JP - Giappone 14
ES - Italia 12
IE - Irlanda 11
NL - Olanda 11
RO - Romania 10
AU - Australia 8
CL - Cile 7
CH - Svizzera 6
KR - Corea 6
BR - Brasile 5
IL - Israele 4
AT - Austria 3
HK - Hong Kong 3
PL - Polonia 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
GR - Grecia 2
HU - Ungheria 2
ID - Indonesia 2
PH - Filippine 2
TH - Thailandia 2
A1 - ???statistics.table.value.countryCode.A1??? 1
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
SG - Singapore 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 14436
Città #
Fairfield 2031
Chandler 898
Ashburn 874
Woodbridge 874
Southend 864
Houston 776
Seattle 680
Wilmington 659
Cambridge 578
Nyköping 504
Ann Arbor 417
Dearborn 392
Jacksonville 354
Princeton 325
Sofia 313
San Diego 271
Modena 203
Eugene 80
Bremen 72
Beijing 70
Izmir 64
Norwalk 56
Dong Ket 41
Redwood City 34
Milan 33
Catania 31
San Jose 31
Rome 28
London 26
Falls Church 23
Belize City 22
Helsinki 22
Fremont 21
Boardman 19
Brussels 16
Des Moines 16
Hefei 15
Albuquerque 14
Solignano 13
Toronto 13
Nanjing 12
Chicago 11
Kunming 10
Ottawa 10
Bologna 9
Cagliari 9
San Mateo 9
Segrate 9
Cingia de' Botti 8
Las Vegas 8
Leawood 8
Nanchang 8
Phoenix 8
Augusta 7
Imola 7
Padova 7
Bogen 6
Florence 6
Fonte Nuova 6
Grafing 6
Guangzhou 6
Indiana 6
Parma 6
Saint Louis 6
Torino 6
Wuhan 6
Arcore 5
Bolton 5
Borås 5
Castelnuovo Rangone 5
Verona 5
Berlin 4
Chiba 4
Madison 4
Mansfield 4
Mijas 4
Perugia 4
Reggio Nell'emilia 4
Sant'Ilario d'Enza 4
Shanghai 4
Trieste 4
Turin 4
Amsterdam 3
Atlanta 3
Avellino 3
Bari 3
Bovisio-Masciago 3
Buffalo 3
Buzau 3
Campobasso 3
Columbus 3
Côré 3
Dallas 3
Gattatico 3
Groningen 3
Hanover 3
Henderson 3
Istanbul 3
Jinan 3
Lisbon 3
Totale 12096
Nome #
Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study 226
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis 215
Risk of ALS and passive long-term residential exposure to pesticides: a population based study. 182
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 181
Selenium Neurotoxicity and Amyotrophic Lateral Sclerosis: An Epidemiologic Perspective 179
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 177
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water 176
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 174
Elevated levels of selenium species in cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated gene mutations. 172
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 162
Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis ? 162
Acute hemichorea as unusual first multiple sclerosis presentation 161
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. 160
Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. 158
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 156
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 154
Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association 153
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 152
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 152
Internal carotid artery dissection: a rare cause of peripheral facial nerve palsy 149
Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment 148
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 147
Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis 145
C9ORF72 and parkinsonism: Weak link, innocent bystander, or central player in neurodegeneration? 145
The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy 143
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 141
Comment on 'Huntington's disease presenting as ALS' 141
Non-invasive and invasive ventilation and enteral nutrition for ALS in Italy. 140
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 139
Population density and risk of Amyotrophic Lateral Sclerosis: an Italian population-based study. 139
Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies 138
Sensory Loss Mimicking Cauda Equina Syndrome due to Cervical Spinal Lesion in a Patient with Clinically Isolated Syndrome 137
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 136
Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: the infectious hypothesis revisited. 135
Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case-control study. 135
Bilateral posterior medullary and cervical stroke: a case report 133
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 129
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A long-term follow-up 129
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 128
Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling 128
Comparison of questionnaire exposure data to land cover map from geographical information system to assess passive exposure to pesticides: a methodological study 127
The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease 125
Epidemiologia e fattori ambientali di rischio della sclerosi laterale amiotrofica sporadica: metodologia di uno studio realizzato in ambiente gis. 124
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 123
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 123
Do flavan-3-ols from green tea reach the human brain? 118
Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. 118
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? 118
Risk stratification of non-traumatic headache in the emergency department 117
Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12 116
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 115
ALS and FTD: Where RNA metabolism meets protein quality control 115
Neurogenic T wave inversion in pure left insular stroke associated with hyperhomocysteinaemia 114
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 113
Amyotrophic lateral sclerosis: Prognostic indicators of survival 112
FATTORI AMBIENTALI DI RISCHIO DELLA SCLEROSI LATERALE AMIOTROFICA: UNO STUDIO CASO-CONTROLLO DI POPOLAZIONE BASATO SU QUESTIONARI ANAMNESTICI 111
Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy. 108
Fattori di rischio ambientali e occupazionali per la sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia Romagna e Sicilia. 105
Endozepines in recurrent stupor 103
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 101
Isolated Hypoglossal nerve palsy due to amyloid cervical arthropathy in long term hemodialysis 100
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 98
VCP AND AUTOPHAGOLYSOSOMAL PATHWAY: GUARDIANS OF PROTEOSTASIS AND STRESS GRANULE DYNAMICS. UNRAVELING THEIR IMPLICATIONS IN ALS 96
Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease 96
Livelli di piombo, cadmio e mercurio nel liquido cerebrospinale e rischio di sclerosi laterale amiotrofica: uno studio caso-controllo. 95
Trace element species and amyotrophic lateral sclerosis with disease associated genetic mutations 95
Risk of ALS and passive residential exposure to pesticides: a population based study. 95
Pesticidi e rischio di sclerosi laterale amiotrofica: il contributo della metodologia gis in uno studio in Emilia-Romagna e in Sicilia. 94
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study 94
Redox speciation of iron, manganese, and copper in cerebrospinal fluid by strong cation exchange chromatography e sector field inductively coupled plasma mass spectrometry. 93
Selenium species and heavy metals in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a hospital-based case-control study 89
Exposure to inorganic selenium in drinking water and incidence of amyotrophic lateral sclerosis: a long-term follow-up of a natural experiment 88
Pesticidi organoclorurati, bifenili policlorurati e idrocarburi aromatici policiclici nel liquido cefalorachidiano di pazienti con sclerosi laterale amiotrofica: uno studio caso-controllo 86
Reply to comment on “environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study” 82
Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study 80
Environmental and occupational exposure to heavy metals and metalloid and development of amyotrophic lateral sclerosis: a population-based case control study in Emilia-Romagna and Sicily. 80
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 75
I pesticidi quali possibili fattori ambientali di rischio nella sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia-Romagna. 73
Cadmium, lead and mercury levels in cerebrospinal fluid and risk of amyotrophic lateral sclerosis – A case-control study. 72
Tolosa hunt sindrome due to actinomycosis of the cavernous sinus: a case report and review of literature 71
Trace element speciation in the cerebrospinal fluid samples from the patients with amyotrophic lateral sclerosis? 68
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 66
Risk of Amyotrophic Lateral Sclerosis and Exposure to Particulate Matter from Vehicular Traffic: A Case-Control Study 62
A CASE-CONTROL STUDY OF NEUROTOXIC METALS IN CEREBROSPINAL FLUID AND RISK OF AMYOTROPHIC LATERAL SCLEROSIS 61
BAG3 and BAG6 differentially affect the dynamics of stress granules by targeting distinct subsets of defective polypeptides released from ribosomes 61
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 55
Fattori di rischio ambientali e occupazionali per la sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia Romagna e Sicilia 55
The NGS technology for the identification of genes associated with the ALS. A systematic review 54
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers 53
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 52
TeleNeurological evaluation and Support for the Emergency Department (TeleNS-ED): protocol for an open-label clinical trial 51
The impact of lifetime alcohol and cigarette smoking loads on amyotrophic lateral sclerosis progression: A cross-sectional study 49
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 45
Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study 44
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 44
The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis 43
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 43
A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements 42
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 41
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 40
Totale 11244
Categoria #
all - tutte 36909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018129 0000 00 067 2916116
2018/20191238 28792339 6772 8131 31114330343
2019/20203003 17713687199 290474 630295 28713320887
2020/20213227 215109153183 312172 153295 466540325304
2021/20224285 347617272155 84205 164197 630394719501
2022/20232318 505366207386 331405 1180 0000
Totale 14912